文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

氢气通过抑制STIM1/ORAI1调控的钙库操作性钙内流减轻脂多糖诱导的肺微血管内皮细胞损伤

HYDROGEN PREVENTS LIPOPOLYSACCHARIDE-INDUCED PULMONARY MICROVASCULAR ENDOTHELIAL CELL INJURY BY INHIBITING STORE-OPERATED Ca 2+ ENTRY REGULATED BY STIM1/ORAI1.
PubMed 文献 · Shock · 2023-11-20
一句话结论动物与细胞实验提示,氢气可减轻脂多糖诱导的肺微血管内皮损伤,机制涉及抑制STIM1/Orai1介导的钙库操作性钙内流。

该研究在脂多糖(LPS)攻击的小鼠与LPS处理的肺微血管内皮细胞(PMVECs)中观察氢气的作用。体内实验显示氢气降低肺湿/干重比、支气管肺泡灌洗液总蛋白与肺通透性,并降低肺微血管内皮STIM1与Orai1表达;体外实验显示LPS上调PMVECs的STIM1与Orai1,氢气逆转该变化并改善钙内流。钙库操作性钙内流抑制剂YM-58483(BTP2)提高细胞活力与连接蛋白表达,而肌浆/内质网钙ATP酶抑制剂毒胡萝卜素降低细胞活力与血管内皮钙黏蛋白、occludin表达。作者认为氢气通过抑制STIM1/Orai1介导的钙库操作性钙内流减轻LPS诱导的PMVEC功能障碍。

要点

  • LPS攻击小鼠中,氢气降低肺湿/干重比、支气管肺泡灌洗液总蛋白及肺通透性,并降低肺微血管内皮STIM1与Orai1表达。
  • 体外LPS处理上调PMVECs的STIM1与Orai1表达,氢气逆转这些变化并改善模拟脓毒症条件下的钙内流。
  • 钙库操作性钙内流抑制剂YM-58483(BTP2)提高PMVECs细胞活力及血管内皮钙黏蛋白、occludin等连接蛋白表达。
  • 肌浆/内质网钙ATP酶抑制剂毒胡萝卜素显著降低细胞活力并减少血管内皮钙黏蛋白与occludin表达。
  • 作者认为氢气通过抑制STIM1与Orai1介导的钙库操作性钙内流,减轻LPS诱导的PMVEC功能障碍。

适用人群与场景

  • LPS攻击的小鼠(在体实验)与LPS处理的肺微血管内皮细胞(体外实验),用于模拟脓毒症相关急性肺损伤。

研究设计与关键结果

  • 研究类型为在体动物实验与体外细胞实验;在体观察氢气对LPS诱导小鼠急性肺损伤的作用,体外观察富氢培养基对LPS处理PMVECs的调控。
  • 在体:氢气降低LPS攻击小鼠的肺湿/干重比、支气管肺泡灌洗液总蛋白与肺通透性,并降低肺微血管内皮STIM1与Orai1表达。
  • 体外:LPS处理上调PMVECs的STIM1与Orai1表达,氢气逆转这些变化;氢气改善模拟脓毒症条件下的钙内流。
  • 体外:毒胡萝卜素处理显著降低细胞活力并减少血管内皮钙黏蛋白与occludin表达;YM-58483(BTP2)处理提高细胞活力与连接蛋白表达。

证据类型、等级与局限

  • 证据类型:在体动物实验与体外细胞实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为氢气治疗通过抑制STIM1与Orai1介导的钙库操作性钙内流,减轻LPS诱导的PMVEC功能障碍。
  • 原文未据此给出临床推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Sepsis is a type of life-threatening organ dysfunction that is caused by a dysregulated host response to infection. The lung is the most vulnerable target organ under septic conditions. Pulmonary microvascular endothelial cells (PMVECs) play a critical role in acute lung injury (ALI) caused by severe sepsis. The impairment of PMVECs during sepsis is a complex regulatory process involving multiple mechanisms, in which the imbalance of calcium (Ca 2+ ) homeostasis of endothelial cells is a key factor in its functional impairment. Our preliminary results indicated that hydrogen gas (H 2 ) treatment significantly alleviates lung injury in sepsis, protects PMVECs from hyperpermeability, and decreases the expression of plasma membrane stromal interaction molecule 1 (STIM1), but the underlying mechanism by which H 2 maintains Ca 2+ homeostasis in endothelial cells in septic models remains unclear. Thus, the purpose of the present study was to investigate the molecular mechanism of STIM1 and Ca 2+ release-activated Ca 2+ channel protein1 (Orai1) regulation by H 2 treatment and explore the effect of H 2 treatment on Ca 2+ homeostasis in lipopolysaccharide (LPS)-induced PMVECs and LPS-challenged mice. Methods: We observed the role of H 2 on LPS-induced ALI of mice in vivo . The lung wet/dry weight ratio, total protein in the bronchoalveolar lavage fluid, and Evans blue dye assay were used to evaluate the pulmonary endothelial barrier damage of LPS-challenged mice. The expression of STIM1 and Orai1 was also detected using epifluorescence microscopy. Moreover, we also investigated the role of H 2 -rich medium in regulating PMVECs under LPS treatment, which induced injury similar to sepsis in vitro . The expression of STIM1 and Orai1 as well as the Ca 2+ concentration in PMVECs was examined. Results:In vivo , we found that H 2 alleviated ALI of mice through decreasing lung wet/dry weight ratio, total protein in the bronchoalveolar lavage fluid and permeability of lung. In addition, H 2 also decreased the expression of STIM1 and Orai1 in pulmonary microvascular endothelium. In vitro , LPS treatment increased the expression levels of STIM1 and Orai1 in PMVECs, while H 2 reversed these changes. Furthermore, H 2 ameliorated Ca 2+ influx under sepsis-mimicking conditions. Treatment with the sarco/endoplasmic reticulum Ca 2+ adenosine triphosphatase inhibitor, thapsigargin, resulted in a significant reduction in cell viability as well as a reduction in the expression of junctional proteins, including vascular endothelial-cadherin and occludin. Treatment with the store-operated Ca 2+ entry inhibitor, YM-58483 (BTP2), increased the cell viability and expression of junctional proteins. Conclusions: The present study suggested that H 2 treatment alleviates LPS-induced PMVEC dysfunction by inhibiting store-operated Ca 2+ entry mediated by STIM1 and Orai1 in vitro and in vivo .

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Li Y, Chen H, Shu R, et al. HYDROGEN PREVENTS LIPOPOLYSACCHARIDE-INDUCED PULMONARY MICROVASCULAR ENDOTHELIAL CELL INJURY BY INHIBITING STORE-OPERATED Ca 2+ ENTRY REGULATED BY STIM1/ORAI1. Shock. 2023. PMID: 38010088. doi:10.1097/SHK.0000000000002279

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。